Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcoma

References

• OttavianiGJaffeNThe epidemiology of osteosarcomaCancer Treat Res200915231320213383
   PubMedGoogle Scholar
• JaffeNAdjuvant chemotherapy in osteosarcoma: An odyssey of rejection and vindicationJaffeNBielackSSBrulandÃSPediatric and Adolescent Osteosarcoma, Cancer Treatment and ResearchNew YorkSpringer2009219238
   Google Scholar
• FerrariSPalmeriniEAdjuvant and neoadjuvant combination chemotherapy for osteogenic sarcomaCurr Opin Oncol200719434134617545797
   PubMed Web of Science ®Google Scholar
• ChouAJGellerDSGorlickRTherapy for osteosarcoma: where do we go from here?Paediatr Drugs200810531532718754698
   PubMedGoogle Scholar
• BuddinghEPAnningaJKVersteeghMIPrognostic factors in pulmonary metastasized high-grade osteosarcomaPediatr Blood Cancer201054221622119890902
   PubMed Web of Science ®Google Scholar
• LewisIJNooijMAWhelanJMRC BO06 and EORTC 80931 collaborators; European Osteosarcoma Intergroup. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma IntergroupJ Natl Cancer Inst200799211212817227995
   PubMed Web of Science ®Google Scholar
• MankinHJHornicekFJRosenbergAEHarmonDCGebhardtMCSurvival data for 648 patients with osteosarcoma treated at one institutionClin Orthop Relat Res200442928629115577500
   PubMed Web of Science ®Google Scholar
• BielackSCarrleDJostLESMO Guidelines Working GroupOsteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-upAnn Oncol200819Suppl 2ii94ii96
   Google Scholar
• PetrilliASde CamargoBFilhoVOBrazilian Osteosarcoma Treatment Group Studies III and IVResults of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survivalJ Clin Oncol20062471161116816505436
   PubMed Web of Science ®Google Scholar
• SakamotoAIwamotoYCurrent status and perspectives regarding the treatment of osteo-sarcoma: chemotherapyRev Recent Clin Trials20083322823118782081
   PubMedGoogle Scholar
• BatanianJRCavalliLRAldosariNMEvaluation of paediatric osteosarcomas by classic cytogenetic and CGH analysesMol Pathol200255638939312456778
   PubMedGoogle Scholar
• GorlickRCurrent concepts on the molecular biology of osteosarcomaCancer Treat Res200915246747820213409
   PubMedGoogle Scholar
• LimGKaraskovaJBeheshtiBAn integrated mBAND and submegabase resolution tiling set (SMRT) CGH array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcomaGenes Chromosomes Cancer200542439240315660435
   PubMed Web of Science ®Google Scholar
• SelvarajahSYoshimotoMMaireGIdentification of cryptic microaberrations in osteosarcoma by high-definition oligonucleotide array comparative genomic hybridizationCancer Genet Cytogenet20071791526117981215
   PubMedGoogle Scholar
• CuiQJiangWGuoJRelationship between hypermethylated MGMT gene and osteosarcoma necrosis rate after chemotherapyPathol Oncol Res20111758759121424568
   PubMed Web of Science ®Google Scholar
• OhJHKimHSKimHHKimWHLeeSHAberrant methylation of p14ARF gene correlates with poor survival in osteosarcomaClin Orthop Relat Res200644221622216394764
   PubMed Web of Science ®Google Scholar
• GorlickRAndersonPAndrulisIBiology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summaryClin Cancer Res20039155442545314654523
   PubMed Web of Science ®Google Scholar
• HermanJGBaylinSBGene silencing in cancer in association with promoter hypermethylationN Engl J Med2003349212042205414627790
   PubMed Web of Science ®Google Scholar
• GeimanTMRobertsonKDChromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?J Cell Biochem200287211712512244565
   PubMed Web of Science ®Google Scholar
• JonesPABaylinSBThe fundamental role of epigenetic events in cancerNat Rev Genet20023641542812042769
   PubMed Web of Science ®Google Scholar
• EstellerMCornPGBaylinSBHermanJGA gene hypermethylation profile of human cancerCancer Res20016183225322911309270
   PubMed Web of Science ®Google Scholar
• TsuchiyaTSekineKHinoharaSNamikiTNoboriTKanekoYAnalysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcomaCancer Genet Cytogenet20001202919810942797
   PubMedGoogle Scholar
• BenassiMSMolendiniLGamberiGInvolvement of INK4A gene products in the pathogenesis and development of human osteosarcomaCancer200192123062306711753985
   PubMed Web of Science ®Google Scholar
• LimSYangMHParkJHInactivation of the RASSF1A in osteosarcomaOncol Rep200310489790112792742
   PubMed Web of Science ®Google Scholar
• Patiño-GarciaAPiñeiroESDíezMZIturriagagoitiaLGKlüssmannFAAriznabarretaLSGenetic and epigenetic alterations of the cell cycle regulators and tumor suppressor genes in pediatric osteosarcomasJ Pediatr Hematol Oncol200325536236712759621
   PubMed Web of Science ®Google Scholar
• HouPJiMYangBQuantitative analysis of promoter hypermethylation in multiple genes in osteosarcomaCancer200610671602160916502411
   PubMed Web of Science ®Google Scholar
• VidalDOPaixãoVABraitMAberrant methylation in pediatric myelodysplastic syndromeLeuk Res200731217518116890288
   PubMed Web of Science ®Google Scholar
• EadsCALordRVWickramasingheKEpigenetic patterns in the progression of esophageal adenocarcinomaCancer Res2001613410341811309301
   PubMed Web of Science ®Google Scholar
• CarvalhoALJeronimoCKimMMEvaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinomaClin Cancer Res2008149710718172258
   PubMed Web of Science ®Google Scholar
• HardenSVTokumaruYWestraWHGene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patientsClin Cancer Res200391370137512684406
   PubMed Web of Science ®Google Scholar
• JeronimoCUsadelHHenriqueRQuantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinomaJ Natl Cancer Inst2001931747175211717336
   PubMed Web of Science ®Google Scholar
• HoqueMOFengQTourePDetection of aberrant methylation of four genes in plasma DNA for the detection of breast cancerJ Clin Oncol2006244262426916908936
   PubMed Web of Science ®Google Scholar
• LehmannULangerFFeistHQuantitative assessment of promoter hypermethylation during breast cancer developmentAm J Pathol200216060561211839581
   PubMed Web of Science ®Google Scholar
• WeisenbergerDJSiegmundKDCampanMCpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNat Genet20063878779316804544
   PubMed Web of Science ®Google Scholar
• de CarvalhoFColleoniGWAlmeidaMSCarvalhoALVettoreALTGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myelomaInt J Cancer200912581985199119548309
   PubMed Web of Science ®Google Scholar
• BrabenderJUsadelHDanenbergKDAdenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survivalOncogene200120273528353211429699
   PubMed Web of Science ®Google Scholar
• EadsCADanenbergKDKawakamiKMethyLight: a high-throughput assay to measure DNA methylationNucleic Acids Res2000288E3210734209
   PubMed Web of Science ®Google Scholar
• RayMEWistowGSuYAMeltzerPSTrentJMAIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanomaProc Natl Acad Sci USA1997947322932349096375
   PubMed Web of Science ®Google Scholar
• BegumSBraitMDasguptaSAn epigenetic marker panel for detection of lung cancer using cell-free serum DNAClin Cancer Res201117134494450321610147
   PubMed Web of Science ®Google Scholar
• BraitMBegumSCarvalhoALAberrant promoter methylation of multiple genes during pathogenesis of bladder cancerCancer Epidemiol Biomarkers Prev200817102786279418843024
   PubMed Web of Science ®Google Scholar
• LoyoMBraitMKimMSA survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinomaInt J Cancer201112861393140320473931
   PubMed Web of Science ®Google Scholar
• TarkkanenMElomaaIBlomqvistCDNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcomaInt J Cancer199984211412110096241
   PubMed Web of Science ®Google Scholar
• FletcherJAGebhardtMCKozakewichHPCytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomesCancer Genet Cytogenet199477181887923089
   PubMedGoogle Scholar
• QuelleDEZindyFAshmunRASherrCJAlternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrestCell199583699310008521522
   PubMed Web of Science ®Google Scholar
• KamijoTZindyFRousselMFTumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARFCell19979156496599393858
   PubMed Web of Science ®Google Scholar
• KamijoTWeberJDZambettiGZindyFRousselMFSherrCJFunctional and physical interactions of the ARF tumor suppressor with p53 and Mdm2Proc Natl Acad Sci USA19989514829282979653180
   PubMed Web of Science ®Google Scholar
• RobertsonKDJonesPAThe human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53Mol Cell Biol19981811645764739774662
   PubMed Web of Science ®Google Scholar
• SailasreeRAbhilashASathyanKMNalinakumariKRThomasSKannanSDifferential roles of p16INK4A and p14ARF genes in prognosis of oral carcinomaCancer Epidemiol Biomarkers Prev200817241442018268126
   PubMed Web of Science ®Google Scholar
• StossiFBarnettDHFrasorJKommBLyttleCRKatzenellenbogenBSTranscriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptorsEndocrinology200414573473348615033914
   PubMed Web of Science ®Google Scholar
• LimaFVicoLLafage-ProustMHvan der SaagPAlexandreCThomasTInteractions between estrogen and mechanical strain effects on U2OS human osteosarcoma cells are not influenced by estrogen receptor typeBone20043551127113515542038
   PubMed Web of Science ®Google Scholar
• BordSHornerABeavanSCompstonJEstrogen receptors alpha and beta are differentially expressed in developing human boneJ Clin Endocrinol Metab20018652309231411344243
   PubMed Web of Science ®Google Scholar
• SusmanEOsteosarcoma: Where Research Is Heading. Skeletal Complications of Malignancy SymposiumOncol Times200527183738
   Google Scholar
• IssaJPOttavianoYLCelanoPHamiltonSRDavidsonNEBaylinSBMethylation of the oestrogen receptor CpG island links ageing and neoplasia in human colonNat Genet1994745365407951326
   PubMed Web of Science ®Google Scholar
• MüllerHMWidschwendterAFieglHDNA methylation in serum of breast cancer patients: an independent prognostic markerCancer Res2003637641764514633683
   PubMed Web of Science ®Google Scholar